Search

  6. ProQR to Present at the JMP Life Sciences Conference

    Press release

    … RNA medicines for the treatment of severe genetic rare diseases, today announced that the company will give a … RNA medicines for the treatment of severe genetic rare diseases such as Leber’s congenital amaurosis 10, …

  7. ProQR to Present at the RBC Capital Markets Healthcare Conference

    Press release

    LEIDEN, the Netherlands and CAMBRIDGE, Mass., May 15, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the treatment of severe genetic rare diseases, today announced